Mpoza, EdwardMukaremera, LilianeAkampurira, AndrewMahsa, Abassi2025-04-142025-04-142018-01-05Mpoza, E., Mukaremera, L., Kundura, D. A., Akampurira, A., Luggya, T., Tadeo, K. K., ... & Abassi, M. (2018). Evaluation of a point-of-care immunoassay test kit ‘StrongStep’for cryptococcal antigen detection. PLoS One, 13(1), e0190652.https://doi.org/10.1371/journal.pone.0190652https://nru.uncst.go.ug/handle/123456789/10618HIV-associated cryptococcal meningitis is the leading cause of adult meningitis in Sub-Saharan Africa, accounting for 15%–20% of AIDS-attributable mortality. The development of point-of-care assays has greatly improved the screening and diagnosis of cryptococcal disease. We evaluated a point-of-care immunoassay, StrongStep (Liming Bio, Nanjing, Jiangsu, China) lateral flow assay (LFA), for cryptococcal antigen (CrAg) detection in cerebrospinal fluid (CSF) and plasma.enArticle